Delivery Order SPE2DB22D3501-SPE2DB24FUR03
Award Date 2/21/24
Potential Completion Date 3/13/24
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $24,999.30 firm fixed price delivery order contract to supply PADCEV 30 MG vials. This award is for the delivery of pharmaceutical products to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,999.58 firm fixed price contract is for the supply of 4565900198 - PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to federal agencies, including the military, and holds several Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for PADCEV 20 MG vials valued at $3,695.90 by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with no set-aside designation applied. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, leveraging the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,046.40, is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of May 5, 2025 and is a firm fixed-price, delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PADCEV 30 MG VIALS. The contract has a ceiling value of $8,315.70 and a period of performance through January 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide $9,999.72 worth of PADCEV 30 MG vials. The award, which does not have a set-aside designation, is for delivery by February 7, 2024. AmerisourceBergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA medical programs...
- The Defense Logistics Agency awarded a delivery order valued at $27,719.00 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials under a firm fixed-price contract structure. The award, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, represents a non-competitive delivery against AmerisourceBergen's larger pharmaceutical supply agreement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, the company's...
- This is a $16,631.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30MG VIALS 1S, a medical product. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $8,315.70 to supply PADCEV 30 mg vials, a pharmaceutical product for oncology treatment. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...